Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Necrobiotic xanthogranuloma.

D A Mehregan1, R K Winkelmann

  • 1Department of Dermatology, Mayo Clinic, Rochester, Minn.

Archives of Dermatology
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Necrobiotic xanthogranuloma is a rare, destructive skin condition often linked to monoclonal gammopathy. Low-dose chlorambucil shows promise as a safe and effective treatment for this chronic disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Engineering a waste management enzyme to overcome cancer resistance to apoptosis: adding DNase1 to the anti-cancer toolbox.

Cancer gene therapy·2011
Same author

Proliferation of sweat ducts in a melanocytic neoplasm.

The American Journal of dermatopathology·2001
Same author

Utility of anti-bacillus Calmette-Guérin antibodies as a screen for organisms in sporotrichoid infections.

Journal of the American Academy of Dermatology·2001
Same author

Cutaneous malakoplakia: a report of two cases with the use of anti-BCG for the detection for micro-organisms.

Journal of the American Academy of Dermatology·2000
Same author

Histologic diagnosis of cutaneous leishmaniasis.

Clinics in dermatology·1999
Same author

Cheilitis due to treatment with simvastatin.

Cutis·1998
Same journal

Scoring With SCORTEN-Reply.

Archives of dermatology·2017
Same journal

Comparison of Early and Late Latent Syphilis- Colorado, 1991.

Archives of dermatology·2016
Same journal

Case of Rhinoscleroma.

Archives of dermatology·2016
Same journal

Cutaneous Fungal Infections.

Archives of dermatology·2016
Same journal

An Ulcerated Plaque in a Gay Man.

Archives of dermatology·2016
Same journal

Solitary Violaceous Nodule on the Face.

Archives of dermatology·2016
See all related articles

Area of Science:

  • Dermatology
  • Pathology
  • Hematology

Background:

  • Necrobiotic xanthogranuloma (NXG) is a rare, destructive xanthogranuloma affecting dermal and subcutaneous tissues.
  • NXG commonly presents on the face, particularly the periorbital region, and trunk.
  • Associated conditions include monoclonal gammopathy (frequently IgG-kappa), cryoglobulinemia, anemia, and leukopenia.

Purpose of the Study:

  • To review cases of necrobiotic xanthogranuloma.
  • To describe the clinical presentation, systemic involvement, and treatment outcomes for NXG.

Main Methods:

  • Retrospective review of 32 patient cases.
  • Inclusion of 16 cases from existing world literature.
  • Analysis of clinical course, laboratory findings, and treatment responses.

Related Experiment Videos

Main Results:

  • NXG is characterized by destructive dermal and subcutaneous lesions, primarily affecting the face and trunk.
  • Common laboratory findings include monoclonal gammopathy (IgG-kappa/lambda), cryoglobulins, low complement, anemia, and leukopenia.
  • Bone marrow examination may reveal plasma cell proliferation or myeloma. Systemic involvement, including myocardial lesions, was observed.

Conclusions:

  • Necrobiotic xanthogranuloma is a chronic, progressive condition with potential systemic manifestations.
  • Low-dose chlorambucil is a safe and effective treatment option.
  • Alternative treatments include corticosteroids, melphalan, radiation, and plasma exchange.